← Back to Search

Caregiver Support Technology for Dementia

N/A

Recruiting

Led By Julie Fields, PhD, LP

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

The participant must have a family member that has been diagnosed with one of the following forms of dementia: Parkinson's/Lewy body dementia, any frontotemporal lobar degeneration dementia, or Alzheimer's dementia.

The participant must identify as a care partner or caregiver who has contact with their loved one with dementia, in person or by phone, and provides social/emotional support and full or partial assistance with daily activities at least 3 days per week.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial is developing a matching process for dementia caregivers to find emotional support and reduce caregiving burden.

Who is the study for?

This trial is for caregivers who have been supporting a loved one with dementia, such as Alzheimer's or Lewy body disease, for at least 3 months. Participants must be English-speaking, able to use the internet and a computer, and willing to engage in the study activities and follow-ups over a period of 15 months.Check my eligibility

What is being tested?

The study aims to develop a technology-based program that matches dementia caregivers for emotional support. It will test if this peer-to-peer support system can improve quality of life and reduce stress by facilitating connections through an algorithm.See study design

What are the potential side effects?

There are no direct medical side effects from participating in this trial since it involves using technology for caregiver support rather than testing medications. However, participants may experience emotional impacts from engaging with others' experiences.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

A family member of mine has been diagnosed with Parkinson's, Lewy body dementia, frontotemporal dementia, or Alzheimer's.

Select...

I regularly help someone with dementia with their daily activities and emotional support.

Select...

I speak English.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change over time from Baseline Quality of Life to 12 months

Change over time from Baseline Resilience to 12 months

Match Satisfaction Questionnaire

+1 more

Secondary outcome measures

Survey of Executive Skills

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Algorithmically MatchedExperimental Treatment1 Intervention

Individuals that identify as a current and/or former caregiver for a person with dementia will be matched to other caregivers using an algorithm that matches a caregiver to another caregiver based on specific preferences each caregiver identifies in a questionnaire.

Group II: Randomly MatchedActive Control1 Intervention

Individuals that identify as a current and/or former caregiver for a person with dementia will be randomly matched to other caregivers not based on the preferences they identified in a questionnaire.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Algorithm

2013

Completed Phase 2

~1340

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,210 Previous Clinical Trials

3,766,899 Total Patients Enrolled

25 Trials studying Dementia

16,742 Patients Enrolled for Dementia

National Institute on Aging (NIA)NIH

1,672 Previous Clinical Trials

28,018,244 Total Patients Enrolled

266 Trials studying Dementia

23,624,941 Patients Enrolled for Dementia

Minnesota HealthSolutionsIndustry Sponsor

11 Previous Clinical Trials

1,106 Total Patients Enrolled

1 Trials studying Dementia

Media Library

Algorithmically Matched Clinical Trial Eligibility Overview. Trial Name: NCT05779839 — N/A

Dementia Research Study Groups: Algorithmically Matched, Randomly Matched

Dementia Clinical Trial 2023: Algorithmically Matched Highlights & Side Effects. Trial Name: NCT05779839 — N/A

Algorithmically Matched 2023 Treatment Timeline for Medical Study. Trial Name: NCT05779839 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining opportunities to join this research study?

"Correct. The details available on clinicaltrials.gov display that this study is actively enrolling patients, having been initially posted on February 22nd 2023. 355 participants are needed at 1 medical facility to complete the trial which was most recently edited on March 9th of the same year."

Answered by AI

How many individuals are participating in this experiment?

"Affirmative. According to clinicaltrials.gov, this research study is presently accepting participants since its inception on February 22nd of 2023 and updated most recently on March 9th of the same year. A total of 355 patients are being sought out by a single medical centre for inclusion in this trial."

Answered by AI